Are you David Alan Lustig?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Publications & Presentations
PubMed
- 49 citationsDiscovery of a novel A2B adenosine receptor antagonist as a clinical candidate for chronic inflammatory airway diseases.Elfatih Elzein, Rao Kalla, Xiaofen Li, Thao Perry, Art Gimbel
Journal of Medicinal Chemistry. 2008-03-06 - 32 citationsNovel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonists.Elfatih Elzein, Rao Kalla, Xiaofen Li, Thao Perry, Parkhill Eric Q
Bioorganic & Medicinal Chemistry Letters. 2006-01-15 - 15 citationsCVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailabilityElfatih Elzein, Prabha Ibrahim, Dmitry Koltun, Ken Rehder, Kevin D. Shenk
Bioorganic & Medicinal Chemistry Letters. 2004-12-20
Office
17741 Sw 2nd St
Pembroke Pines, FL 33029Phone+1 954-437-3300Fax+1 954-437-1011
